Skip to Content

Pfizer DCB30 (Vizimpro 30 mg)

Generic Name: dacomitinib

Pill with imprint Pfizer DCB30 is Blue, Round and has been identified as Vizimpro 30 mg. It is supplied by Pfizer Inc..

Vizimpro is used in the treatment of non-small cell lung cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. Vizimpro 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer DCB30

Vizimpro

Generic Name
dacomitinib
Imprint
Pfizer DCB30
Strength
30 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors, HER2 inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-1198

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.